NewTimeSpace News: TIANJIN PHARM DA REN TANG GRP released an announcement on February 11, 2026, disclosing the latest progress regarding the listing rule exemptions granted by SGX, confirming that the company has fulfilled most of the requirements for the relevant exemption conditions in the 2025 fiscal year, and the exemptions remain valid.

According to the announcement, SGX granted TIANJIN PHARM DA REN TANG GRP three "evergreen exemptions" on February 2, 2024, involving exemptions from complying with the relevant provisions of Rules 705(1), 707(1), and 730A(1) of the Listing Manual. The exemptions remain valid only if specific conditions are met, and this announcement focuses on the fulfillment of the relevant conditions for the 2025 fiscal year (ended December 31, 2025).

Specifically, the three exemptions and their condition fulfillment status are as follows:

1.Exemption from Rule 705(1) (allowing the company to delay the disclosure of audited full-year results by 30 days): All conditions have been met except for the requirement to disclose the audited full-year results for the 2025 fiscal year by March 31, 2026.

2.Exemption from Rule 707(1) (allowing the company to delay the convening of the annual general meeting (AGM) by up to 30 days): All conditions have been fully satisfied except for the requirement to convene the 2025 fiscal year AGM by May 15, 2026, with relevant confirmations and commitments submitted on time.

3.Exemption from Rule 730A(1) (allowing the company to not hold all AGMs in Singapore): All relevant conditions for this exemption have been met.

The announcement clarified that Tianshili Daren Tang had submitted all required documents such as confirmations and commitment letters to SGX on January 16, 2026, in relation to the conditions for the above three exemptions, fulfilling the corresponding information disclosure and document submission obligations. On February 10, 2026, SGX officially informed the company that based on the submission of the aforementioned documents, the evergreen exemptions remain valid.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.